As Fierce Pharma points out, patent expirations are a routine occurrence in the pharmaceutical world, but 2025 stands out for ...

Using vedolizumab first, before tumor necrosis factor-α inhibitors, improved quality-adjusted life-years in both ulcerative ...

OSE Immunotherapeutics to Present Groundbreaking Extension Period Data on Lusvertikimab at DDW 2025New Clinical Data from ...

In April 2025, Janssen Research & Development, LLC announced a study is to evaluate the efficacy, including clinical ...

Palatin Technologies, Inc. (NYSE American: PTN), a biopharmaceutical company developing first-in-class medicines based on ...

Inflammatory bowel disease (IBD) is associated with increased risks for genitourinary cancers, including prostate cancer and renal cell carcinoma (RCC), according to study results presented at the ...

Auburn football kicker Alex McPherson was sidelined for much of 2024 with ongoing health issues. On Wednesday, he discussed ...

The 2024 season could best be described as one of hardship and frustration for Auburn kicker Alex McPherson. He made just one appearance all year due to a lingering gastrointestinal illness, which was ...

Community members gathered for a different kind of walk on Saturday, looking to raise awareness for two medical conditions.

Fecal transplants may lead to remission in some people with ulcerative colitis (UC), although more research is needed. Medications and lifestyle modifications are other ways to manage the condition.

The drug-funding agency estimated that 1200 patients would benefit this year, rising to more than 5000 annually after 2030.

Palisade Bio (PALI) announced the completion of enrollment and dosing in all five Phase 1a SAD cohorts, all four MAD cohorts, and the food ...